Skip to content

Laparoscopic Guided Peri-wound Transversus Abdominis Plane Block With Bupivacaine Versus Local Wound Infiltration on Post-op Opioid Use in Laparoscopic Sleeve Gastrectomy

Comparison of Laparoscopic Guided Peri-wound Transversus Abdominis Plane Block With Bupivacaine Versus Local Wound Infiltration on Post-op Opioid Use in Laparoscopic Sleeve Gastrectomy, A Prospective Randomized Controlled Study

Status
Recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05930184
Enrollment
98
Registered
2023-07-05
Start date
2023-04-29
Completion date
2024-12-31
Last updated
2024-05-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Morbid Obesity, Laparoscopic Sleeve Gastrectomy, Transversus Abdominis Plane Block, Local Wound Infiltration, Bupivacine, Opioid Use

Brief summary

The goal of this randomized controlled trial is to compare laparoscopic guided peri-wound Transversus Abdominis Plane Block and bupivacaine versus local wound infiltration effect on reducing post-op opioid use in Laparoscopic Sleeve gastrectomy. The main questions it aims to answer are: • Can laparoscopic guided peri-wound Transversus Abdominis Plane Block reduced post operative morphine usage when comparing with local wound port site infiltration. Participants will be randomize into 2 group * peri-wound Transversus Abdominis Plane Block * local wound port site infiltration

Interventions

PROCEDUREperi-wound Transversus Abdominis Plane Block

0.25% bupivacaine 20ml was injected using no24 needle into a plane between internal oblique muscle and transversus abdominis muscle around every wound 2 cm. from wound opening. The procedure was confirmed by laparoscopic vision and the injection was done before removal of laparoscopic port.

0.25% bupivacaine 20ml was injected using no24 needle into subcutaneous tissue after the abdominal sheet was sutured.

Sponsors

Khon Kaen University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Intervention model description

Periwound-TAP block using 0.25%Bupivacain 20ml and local wound infiltration using 0.25%Bupivacain 20ml

Eligibility

Sex/Gender
ALL
Age
18 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

* patient undergoing LSG at Sringarind hospital as indicated by Thai guideline

Exclusion criteria

* Allergic/contraindicated to bupivacaine, morphine, fentanyl, NSAIDs or Nefopam * Unable to describe pain score Opioid addict * denied consent

Design outcomes

Primary

MeasureTime frame
Cumulative morphine use48hours after intervention

Secondary

MeasureTime frame
Post op VAS pain score48hours after intervention
length of hospital staywithin admission
opioid side effectwithin admission
PACU time1day after intervention
postop complication2weeks after intervention

Countries

Thailand

Contacts

Primary ContactThanatat Panitphong, Doctor of Medicine
thanatat.panitphong@gmail.com+66888868621
Backup ContactSuriya Punchai, Assistant Professor
+6686-8624484

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026